Liverpool
Liverpool ECMC aims to advance experimental cancer medicine by conducting early phase (phase I/II) clinical trials and performing molecular analysis of patients’ blood and tumour samples.
Research activities have been facilitated by the opening of new laboratories, enabling sample collection, storage, processing, and downstream translational research studies. Studies are conducted on various cancer types.
Research Areas
Focus
Pharmacokinetics (PK) and Pharmacodynamics (PD), Proteomic and Molecular analysis of clinical samples.
Disease Area
Pancreas, head and neck, ovarian, gastro-intestinal and other solid tumours; lymphomas and other haematological malignancies.
Goals
Skills
Liverpool ECMC principal investigators and staff have a range of skills and expertise.
Facilities
Liverpool principal investigators and staff have a diverse range of skills and expertise.
Achievements
To learn more about the scientific and operational achievements of Liverpool ECMC go to:
Centre Leads
Professor Dan Palmer
Department of Molecular and Clinical Cancer Medicine
The Duncan Building
University of Liverpool
Daulby Street
Liverpool
L69 3GA
and
Professor John P Neoptolemos, MA, MB, BChir, MD, FRCS, FMedSci
Head of School of Cancer Studies
Head Division of Surgery and Oncology
The Duncan Building
Daulby Street
Liverpool
L69 3GA
Tel: +44 (0)151 706 4175
Fax: +44 (0)151 706 5798
University of Liverpool Division of Surgery and Oncology website
General and Patient Enquiries
Gary Jeffers
Liverpool ECMC Co-ordinator
Cancer Research UK Liverpool Cancer Trials Unit
University of Liverpool Cancer Research Centre
200 London Road
Liverpool
L3 9TA
Tel: +44(0)151 706 4890
Fax: +44 (0) 151 794 8930/8931
You can also find out about trials recruiting in Liverpool on the CancerHelp UK clinical trials database.
Increase text
Decrease text
Print this page